Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 393

1.

A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function.

Miramontes-Gonzalez JP, Hightower M, Zhang K, Kurosaki H, Schork AJ, Biswas N, Vaingankar S, Mahata M, Lipkowitz MS, Nievergelt CM, Baker DG, Ziegler MG, León-Jiménez D, González-Sarmiento R, Ichinose H, O'Connor DT.

Sci Rep. 2019 Mar 25;9(1):5055. doi: 10.1038/s41598-019-41504-7.

2.

Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk.

Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, Hwang SJ, Jaju D, Kerr KF, Kluttig A, Krijthe BP, Kumar J, van der Laan SW, Lyytikäinen LP, Maihofer AX, Minassian A, van der Most PJ, Müller-Nurasyid M, Nivard M, Salvi E, Stewart JD, Thayer JF, Verweij N, Wong A, Zabaneh D, Zafarmand MH, Abdellaoui A, Albarwani S, Albert C, Alonso A, Ashar F, Auvinen J, Axelsson T, Baker DG, de Bakker PIW, Barcella M, Bayoumi R, Bieringa RJ, Boomsma D, Boucher G, Britton AR, Christophersen I, Dietrich A, Ehret GB, Ellinor PT, Eskola M, Felix JF, Floras JS, Franco OH, Friberg P, Gademan MGJ, Geyer MA, Giedraitis V, Hartman CA, Hemerich D, Hofman A, Hottenga JJ, Huikuri H, Hutri-Kähönen N, Jouven X, Junttila J, Juonala M, Kiviniemi AM, Kors JA, Kumari M, Kuznetsova T, Laurie CC, Lefrandt JD, Li Y, Li Y, Liao D, Limacher MC, Lin HJ, Lindgren CM, Lubitz SA, Mahajan A, McKnight B, Zu Schwabedissen HM, Milaneschi Y, Mononen N, Morris AP, Nalls MA, Navis G, Neijts M, Nikus K, North KE, O'Connor DT, Ormel J, Perz S, Peters A, Psaty BM, Raitakari OT, Risbrough VB, Sinner MF, Siscovick D, Smit JH, Smith NL, Soliman EZ, Sotoodehnia N, Staessen JA, Stein PK, Stilp AM, Stolarz-Skrzypek K, Strauch K, Sundström J, Swenne CA, Syvänen AC, Tardif JC, Taylor KD, Teumer A, Thornton TA, Tinker LE, Uitterlinden AG, van Setten J, Voss A, Waldenberger M, Wilhelmsen KC, Willemsen G, Wong Q, Zhang ZM, Zonderman AB, Cusi D, Evans MK, Greiser HK, van der Harst P, Hassan M, Ingelsson E, Järvelin MR, Kääb S, Kähönen M, Kivimaki M, Kooperberg C, Kuh D, Lehtimäki T, Lind L, Nievergelt CM, O'Donnell CJ, Oldehinkel AJ, Penninx B, Reiner AP, Riese H, van Roon AM, Rioux JD, Rotter JI, Sofer T, Stricker BH, Tiemeier H, Vrijkotte TGM, Asselbergs FW, Brundel BJJM, Heckbert SR, Whitsel EA, den Hoed M, Snieder H, de Geus EJC.

Nat Commun. 2017 Aug 2;8:16140. doi: 10.1038/ncomms16140.

3.

Genetic loci associated with heart rate variability and their effects on cardiac disease risk.

Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, Hwang SJ, Jaju D, Kerr KF, Kluttig A, Krijthe BP, Kumar J, van der Laan SW, Lyytikäinen LP, Maihofer AX, Minassian A, van der Most PJ, Müller-Nurasyid M, Nivard M, Salvi E, Stewart JD, Thayer JF, Verweij N, Wong A, Zabaneh D, Zafarmand MH, Abdellaoui A, Albarwani S, Albert C, Alonso A, Ashar F, Auvinen J, Axelsson T, Baker DG, de Bakker PIW, Barcella M, Bayoumi R, Bieringa RJ, Boomsma D, Boucher G, Britton AR, Christophersen I, Dietrich A, Ehret GB, Ellinor PT, Eskola M, Felix JF, Floras JS, Franco OH, Friberg P, Gademan MGJ, Geyer MA, Giedraitis V, Hartman CA, Hemerich D, Hofman A, Hottenga JJ, Huikuri H, Hutri-Kähönen N, Jouven X, Junttila J, Juonala M, Kiviniemi AM, Kors JA, Kumari M, Kuznetsova T, Laurie CC, Lefrandt JD, Li Y, Li Y, Liao D, Limacher MC, Lin HJ, Lindgren CM, Lubitz SA, Mahajan A, McKnight B, Zu Schwabedissen HM, Milaneschi Y, Mononen N, Morris AP, Nalls MA, Navis G, Neijts M, Nikus K, North KE, O'Connor DT, Ormel J, Perz S, Peters A, Psaty BM, Raitakari OT, Risbrough VB, Sinner MF, Siscovick D, Smit JH, Smith NL, Soliman EZ, Sotoodehnia N, Staessen JA, Stein PK, Stilp AM, Stolarz-Skrzypek K, Strauch K, Sundström J, Swenne CA, Syvänen AC, Tardif JC, Taylor KD, Teumer A, Thornton TA, Tinker LE, Uitterlinden AG, van Setten J, Voss A, Waldenberger M, Wilhelmsen KC, Willemsen G, Wong Q, Zhang ZM, Zonderman AB, Cusi D, Evans MK, Greiser HK, van der Harst P, Hassan M, Ingelsson E, Järvelin MR, Kääb S, Kähönen M, Kivimaki M, Kooperberg C, Kuh D, Lehtimäki T, Lind L, Nievergelt CM, O'Donnell CJ, Oldehinkel AJ, Penninx B, Reiner AP, Riese H, van Roon AM, Rioux JD, Rotter JI, Sofer T, Stricker BH, Tiemeier H, Vrijkotte TGM, Asselbergs FW, Brundel BJJM, Heckbert SR, Whitsel EA, den Hoed M, Snieder H, de Geus EJC.

Nat Commun. 2017 Jun 14;8:15805. doi: 10.1038/ncomms15805. Erratum in: Nat Commun. 2017 Aug 02;8:16140.

4.

iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.

Panopoulos AD, D'Antonio M, Benaglio P, Williams R, Hashem SI, Schuldt BM, DeBoever C, Arias AD, Garcia M, Nelson BC, Harismendy O, Jakubosky DA, Donovan MKR, Greenwald WW, Farnam K, Cook M, Borja V, Miller CA, Grinstein JD, Drees F, Okubo J, Diffenderfer KE, Hishida Y, Modesto V, Dargitz CT, Feiring R, Zhao C, Aguirre A, McGarry TJ, Matsui H, Li H, Reyna J, Rao F, O'Connor DT, Yeo GW, Evans SM, Chi NC, Jepsen K, Nariai N, Müller FJ, Goldstein LSB, Izpisua Belmonte JC, Adler E, Loring JF, Berggren WT, D'Antonio-Chronowska A, Smith EN, Frazer KA.

Stem Cell Reports. 2017 Apr 11;8(4):1086-1100. doi: 10.1016/j.stemcr.2017.03.012.

5.

Identification of novel loci affecting circulating chromogranins and related peptides.

Benyamin B, Maihofer AX, Schork AJ, Hamilton BA, Rao F, Schmid-Schönbein GW, Zhang K, Mahata M, Stridsberg M, Schork NJ, Biswas N, Hook VY, Wei Z, Montgomery GW, Martin NG, Nievergelt CM, Whitfield JB, O'Connor DT.

Hum Mol Genet. 2017 Jan 1;26(1):233-242. doi: 10.1093/hmg/ddw380.

6.

Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.

Biswas N, Maihofer AX, Mir SA, Rao F, Zhang K, Khandrika S, Mahata M, Friese RS, Hightower CM, Mahata SK, Baker DG, Nievergelt CM, Vaingankar SM, O'Connor DT.

BMC Med Genet. 2016 Mar 11;17:21. doi: 10.1186/s12881-016-0283-5.

7.

Miscibility Gap Closure, Interface Morphology, and Phase Microstructure of 3D Li(x)FePO4 Nanoparticles from Surface Wetting and Coherency Strain.

Welland MJ, Karpeyev D, O'Connor DT, Heinonen O.

ACS Nano. 2015 Oct 27;9(10):9757-71. doi: 10.1021/acsnano.5b02555. Epub 2015 Sep 21.

PMID:
26355590
8.

Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.

Rao F, Schork AJ, Maihofer AX, Nievergelt CM, Marcovina SM, Miller ER, Witztum JL, O'Connor DT, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1704-11. doi: 10.1161/ATVBAHA.115.305306. Epub 2015 May 7.

9.

Gene networks specific for innate immunity define post-traumatic stress disorder.

Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, Risbrough VB, Baker DG, O'Connor DT, Nievergelt CM, Woelk CH.

Mol Psychiatry. 2015 Dec;20(12):1538-45. doi: 10.1038/mp.2015.9. Epub 2015 Mar 10.

10.

Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene.

Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, Logue MW, Geyer MA, Risbrough VB, O'Connor DT, Baker DG.

Psychoneuroendocrinology. 2015 Jan;51:459-71. doi: 10.1016/j.psyneuen.2014.10.017. Epub 2014 Oct 30.

PMID:
25456346
11.

Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Zhang K, Mir SA, Hightower CM, Miramontes-Gonzalez JP, Maihofer AX, Chen Y, Mahata SK, Nievergelt CM, Schork NJ, Freedman BI, Vaingankar SM, O'Connor DT.

J Am Soc Nephrol. 2015 Aug;26(8):1816-25. doi: 10.1681/ASN.2014060537. Epub 2014 Nov 12.

12.

Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice.

Vu CU, Siddiqui JA, Wadensweiler P, Gayen JR, Avolio E, Bandyopadhyay GK, Biswas N, Chi NW, O'Connor DT, Mahata SK.

Endocrinology. 2014 Oct;155(10):3793-805. doi: 10.1210/en.2014-1320. Epub 2014 Jul 22.

PMID:
25051446
13.

Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.

Bandyopadhyay GK, Lu M, Avolio E, Siddiqui JA, Gayen JR, Wollam J, Vu CU, Chi NW, O'Connor DT, Mahata SK.

Diabetes. 2015 Jan;64(1):104-16. doi: 10.2337/db13-1747. Epub 2014 Jul 21.

14.

The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.

Mustapic M, Maihofer AX, Mahata M, Chen Y, Baker DG, O'Connor DT, Nievergelt CM.

Hum Mol Genet. 2014 Dec 1;23(23):6375-84. doi: 10.1093/hmg/ddu332. Epub 2014 Jun 30.

15.

Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.

Minassian A, Geyer MA, Baker DG, Nievergelt CM, O'Connor DT, Risbrough VB; Marine Resiliency Study Team.

Psychosom Med. 2014 May;76(4):292-301. doi: 10.1097/PSY.0000000000000056.

16.

Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.

Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, O'Connor DT, Baker DG; Marine Resiliency Study Team.

JAMA Psychiatry. 2014 Apr;71(4):423-31. doi: 10.1001/jamapsychiatry.2013.4374.

17.

Imputing observed blood pressure for antihypertensive treatment: impact on population and genetic analyses.

Rana BK, Dhamija A, Panizzon MS, Spoon KM, Vasilopoulos T, Franz CE, Grant MD, Jacobson KC, Kim K, Lyons MJ, McCaffery JM, Stein PK, Xian H, O'Connor DT, Kremen WS.

Am J Hypertens. 2014 Jun;27(6):828-37. doi: 10.1093/ajh/hpt271. Epub 2014 Feb 14.

18.

Genetic implication of a novel thiamine transporter in human hypertension.

Zhang K, Huentelman MJ, Rao F, Sun EI, Corneveaux JJ, Schork AJ, Wei Z, Waalen J, Miramontes-Gonzalez JP, Hightower CM, Maihofer AX, Mahata M, Pastinen T, Ehret GB; International Consortium for Blood Pressure Genome-Wide Association Studies, Schork NJ, Eskin E, Nievergelt CM, Saier MH Jr, O'Connor DT.

J Am Coll Cardiol. 2014 Apr 22;63(15):1542-55. doi: 10.1016/j.jacc.2014.01.007. Epub 2014 Feb 5.

19.

Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism.

Biswas N, Friese RS, Gayen JR, Bandyopadhyay G, Mahata SK, O'Connor DT.

PLoS One. 2014 Jan 20;9(1):e84132. doi: 10.1371/journal.pone.0084132. eCollection 2014.

20.

Heritable influence of DBH on adrenergic and renal function: twin and disease studies.

Pasha DN, Davis JT, Rao F, Chen Y, Wen G, Fung MM, Mahata M, Zhang K, Trzebinska D, Mustapic M, Hightower CM, Lipkowitz MS, Ji M, Ziegler MG, Nievergelt CM, O'Connor DT.

PLoS One. 2013 Dec 31;8(12):e82956. doi: 10.1371/journal.pone.0082956. eCollection 2013. Erratum in: PLoS One. 2014;9(6):e100351.

21.

Chromogranin B: intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms.

Zhang K, Biswas N, Gayen JR, Miramontes-Gonzalez JP, Hightower CM, Mustapic M, Mahata M, Huang CT, Hook VY, Mahata SK, Vaingankar S, O'Connor DT.

J Neurochem. 2014 Apr;129(1):48-59. doi: 10.1111/jnc.12527. Epub 2013 Nov 25.

22.

Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected].

Zhang K, Deacon DC, Rao F, Schork AJ, Fung MM, Waalen J, Schork NJ, Nievergelt CM, Chi NC, O'Connor DT.

J Am Coll Cardiol. 2014 Feb 4;63(4):358-68. doi: 10.1016/j.jacc.2013.09.025. Epub 2013 Oct 16. Erratum in: J Am Coll Cardiol. 2014 Mar 25;63(11):1122.

23.

Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue.

Borges R, Dominguez N, Smith CB, Bandyopadhyay GK, O'Connor DT, Mahata SK, Bartolomucci A.

Adv Pharmacol. 2013;68:93-113. doi: 10.1016/B978-0-12-411512-5.00005-1. Review.

PMID:
24054141
24.

Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension.

Tsigelny IF, Kouznetsova VL, Biswas N, Mahata SK, O'Connor DT.

Bioorg Med Chem. 2013 Sep 15;21(18):5855-69. doi: 10.1016/j.bmc.2013.07.008. Epub 2013 Jul 17.

PMID:
23916146
25.

Reply to Rampoldi et al.

Chen Y, O'Connor DT.

Kidney Int. 2013 Aug;84(2):411-3. doi: 10.1038/ki.2013.164. No abstract available.

26.

Genetic variation at the delta-sarcoglycan (SGCD) locus elevates heritable sympathetic nerve activity in human twin pairs.

Hightower CM, Zhang K, Miramontes-González JP, Rao F, Wei Z, Schork AJ, Nievergelt CM, Biswas N, Mahata M, Elkelis N, Taupenot L, Stridsberg M, Ziegler MG, O'Connor DT.

J Neurochem. 2013 Dec;127(6):750-61. doi: 10.1111/jnc.12346. Epub 2013 Jul 19.

27.

Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe.

Baker DG, Bertram TM, Patel PM, Barkauskas DA, Clopton P, Patel S, Geracioti TD Jr, Haji U, O'Connor DT, Nievergelt CM, Hauger RL.

Psychoneuroendocrinology. 2013 Oct;38(10):2378-82. doi: 10.1016/j.psyneuen.2013.04.020. Epub 2013 Jun 10.

PMID:
23759334
28.

MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.

Friese RS, Altshuler AE, Zhang K, Miramontes-Gonzalez JP, Hightower CM, Jirout ML, Salem RM, Gayen JR, Mahapatra NR, Biswas N, Cale M, Vaingankar SM, Kim HS, Courel M, Taupenot L, Ziegler MG, Schork NJ, Pravenec M, Mahata SK, Schmid-Schönbein GW, O'Connor DT.

Hum Mol Genet. 2013 Sep 15;22(18):3624-40. doi: 10.1093/hmg/ddt213. Epub 2013 May 13.

29.

The influence of acute resistance exercise on cyclooxygenase-1 and -2 activity and protein levels in human skeletal muscle.

Carroll CC, O'Connor DT, Steinmeyer R, Del Mundo JD, McMullan DR, Whitt JA, Ramos JE, Gonzales RJ.

Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R24-30. doi: 10.1152/ajpregu.00593.2012. Epub 2013 May 1.

30.

Association of functional kallikrein-1 promoter polymorphisms and acute kidney injury: a case-control and longitudinal cohort study.

Susantitaphong P, Perianayagam MC, Kang SW, Zhang W, Rao F, O'Connor DT, Jaber BL.

Nephron Clin Pract. 2012;122(3-4):107-13. doi: 10.1159/000350733. Epub 2013 Apr 25.

31.

Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels.

Han J, Liu Y, Rao F, Nievergelt CM, O'Connor DT, Wang X, Liu L, Bu D, Liang Y, Wang F, Zhang L, Zhang H, Chen Y, Wang H.

Kidney Int. 2013 Apr;83(4):733-40. doi: 10.1038/ki.2012.449. Epub 2013 Jan 23.

32.

Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.

Davis JT, Pasha DN, Khandrika S, Fung MM, Milic M, O'Connor DT.

J Clin Hypertens (Greenwich). 2013 Jan;15(1):69-74. doi: 10.1111/jch.12031. Epub 2012 Oct 26.

33.

Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs.

Wei Z, Zhang K, Wen G, Balasubramanian K, Shih PA, Rao F, Friese RS, Miramontes-Gonzalez JP, Schmid-Schoenbein GW, Kim HS, Mahata SK, O'Connor DT.

J Hypertens. 2013 Jan;31(1):123-33. doi: 10.1097/HJH.0b013e32835b053d.

34.

Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertension.

Biswas N, Gayen J, Mahata M, Su Y, Mahata SK, O'Connor DT.

Hypertension. 2012 Dec;60(6):1552-9. doi: 10.1161/HYPERTENSIONAHA.112.202127. Epub 2012 Nov 5.

35.

Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.

Zhang K, Rao F, Miramontes-Gonzalez JP, Hightower CM, Vaught B, Chen Y, Greenwood TA, Schork AJ, Wang L, Mahata M, Stridsberg M, Khandrika S, Biswas N, Fung MM, Waalen J, Middelberg RP, Heath AC, Montgomery GW, Martin NG, Whitfield JB, Baker DG, Schork NJ, Nievergelt CM, O'Connor DT.

J Am Coll Cardiol. 2012 Oct 23;60(17):1678-89. doi: 10.1016/j.jacc.2012.06.042. Epub 2012 Sep 26. Erratum in: J Am Coll Cardiol. 2012 Nov 20;60(21):2261.

36.

The protein architecture of human secretory vesicles reveals differential regulation of signaling molecule secretion by protein kinases.

Bark SJ, Wegrzyn J, Taupenot L, Ziegler M, O'Connor DT, Ma Q, Smoot M, Ideker T, Hook V.

PLoS One. 2012;7(8):e41134. doi: 10.1371/journal.pone.0041134. Epub 2012 Aug 16.

37.

Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure.

Mbewe-Campbell N, Wei Z, Zhang K, Friese RS, Mahata M, Schork AJ, Rao F, Chiron S, Biswas N, Kim HS, Mahata SK, Waalen J, Nievergelt CM, Hook VY, O'Connor DT.

J Hypertens. 2012 Oct;30(10):1961-9.

38.

Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressure.

Bhatnagar V, Liu L, Nievergelt CM, Richard E, Brophy VH, Pandey B, Lipkowitz MS, O'Connor DT.

Am J Hypertens. 2012 Nov;25(11):1188-94. doi: 10.1038/ajh.2012.106. Epub 2012 Aug 2.

39.

Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes.

Perianayagam MC, Tighiouart H, Liangos O, Kouznetsov D, Wald R, Rao F, O'Connor DT, Jaber BL.

Kidney Int. 2012 Oct;82(8):909-19. doi: 10.1038/ki.2012.235. Epub 2012 Jun 27.

40.

Autonomic and hemodynamic origins of pre-hypertension: central role of heredity.

Davis JT, Rao F, Naqshbandi D, Fung MM, Zhang K, Schork AJ, Nievergelt CM, Ziegler MG, O'Connor DT.

J Am Coll Cardiol. 2012 Jun 12;59(24):2206-16. doi: 10.1016/j.jacc.2012.02.040.

41.

Integrated computational and experimental analysis of the neuroendocrine transcriptome in genetic hypertension identifies novel control points for the cardiometabolic syndrome.

Friese RS, Ye C, Nievergelt CM, Schork AJ, Mahapatra NR, Rao F, Napolitan PS, Waalen J, Ehret GB, Munroe PB, Schmid-Schönbein GW, Eskin E, O'Connor DT.

Circ Cardiovasc Genet. 2012 Aug 1;5(4):430-40. doi: 10.1161/CIRCGENETICS.111.962415. Epub 2012 Jun 5.

42.

Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study.

Baker DG, Nash WP, Litz BT, Geyer MA, Risbrough VB, Nievergelt CM, O'Connor DT, Larson GE, Schork NJ, Vasterling JJ, Hammer PS, Webb-Murphy JA; MRS Team.

Prev Chronic Dis. 2012;9:E97. Epub 2012 May 10.

43.

Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries.

Zuloaga KL, O'Connor DT, Handa RJ, Gonzales RJ.

Steroids. 2012 Jul;77(8-9):835-44. doi: 10.1016/j.steroids.2012.04.013. Epub 2012 Apr 20.

44.

Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.

Bandyopadhyay GK, Vu CU, Gentile S, Lee H, Biswas N, Chi NW, O'Connor DT, Mahata SK.

J Biol Chem. 2012 Jun 29;287(27):23141-51. doi: 10.1074/jbc.M111.335877. Epub 2012 Apr 25.

45.

Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension.

Cowley AW Jr, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH, Harrison DG, Liang M, Nathanielsz PW, O'Connor DT, Ordovas J, Peng W, Soares MB, Szyf M, Tolunay HE, Wood KC, Zhao K, Galis ZS.

Hypertension. 2012 May;59(5):899-905. doi: 10.1161/HYPERTENSIONAHA.111.190116. Epub 2012 Mar 19. Review. No abstract available.

46.

Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters.

Funkelstein L, Lu WD, Koch B, Mosier C, Toneff T, Taupenot L, O'Connor DT, Reinheckel T, Peters C, Hook V.

J Biol Chem. 2012 May 4;287(19):15232-41. doi: 10.1074/jbc.M111.310607. Epub 2012 Mar 5.

47.

Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins.

Rao F, Chiron S, Wei Z, Fung MM, Chen Y, Wen G, Khandrika S, Ziegler MG, Benyamin B, Montgomery G, Whitfield JB, Martin NG, Waalen J, Hamilton BA, Mahata SK, O'Connor DT.

Am J Hypertens. 2012 Jan;25(1):29-40. doi: 10.1038/ajh.2011.163. Epub 2011 Sep 15.

48.

GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Benyamin B, Middelberg RP, Lind PA, Valle AM, Gordon S, Nyholt DR, Medland SE, Henders AK, Heath AC, Madden PA, Visscher PM, O'Connor DT, Montgomery GW, Martin NG, Whitfield JB.

Hum Mol Genet. 2011 Nov 15;20(22):4504-14. doi: 10.1093/hmg/ddr375. Epub 2011 Aug 23.

49.

Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences.

Kang SW, Shih PA, Mathew RO, Mahata M, Biswas N, Rao F, Yan L, Bouchard J, Malhotra R, Tolwani A, Khandrika S, Mehta RL, O'Connor DT.

BMC Nephrol. 2011 Jun 16;12:27. doi: 10.1186/1471-2369-12-27.

50.

Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Fung MM, Salem RM, Lipkowitz MS, Bhatnagar V, Pandey B, Schork NJ, O'Connor DT; AASK Study Investigators.

Nephrol Dial Transplant. 2012 Jan;27(1):197-205. doi: 10.1093/ndt/gfr257. Epub 2011 May 25.

Supplemental Content

Loading ...
Support Center